Leerink Partners Raised Price Target on Bruker (BRKR) Following Strong 4Q
Leerink Partners reiterated an Outperform rating on Bruker (NASDAQ: BRKR), and raised the price target to $26.00 (from $25.00). 4Q ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)